BONESUPPORT (Q2 Initial take): In line with expectations but modest guidance change - Redeye
Bildkälla: Stockfoto

BONESUPPORT (Q2 Initial take): In line with expectations but modest guidance change - Redeye

The deviation in Q2 was relatively insignificant, but the company's comments on lower-than-expected sales growth in Q2, together with a slight change to its 2026e constant currency sales growth target, are likely to weigh on the share today by a few percentage points.

The deviation in Q2 was relatively insignificant, but the company's comments on lower-than-expected sales growth in Q2, together with a slight change to its 2026e constant currency sales growth target, are likely to weigh on the share today by a few percentage points.
Börsvärldens nyhetsbrev